Hims & Hers Debuts Super Bowl Ad Advocating for Affordable Weight-Loss Drugs

The telehealth company challenges high drug prices with a bold ad highlighting systemic issues in the weight-loss industry.

Hims & Hers is airing its first-ever Super Bowl commercial during the third quarter of Super Bowl LIX, spending an estimated $14 million on the one-minute spot.
The ad criticizes the high costs of branded GLP-1 weight-loss drugs like Ozempic and Wegovy, which are often inaccessible to many due to shortages and pricing.
Hims & Hers offers a more affordable, compounded version of semaglutide, the active ingredient in these drugs, for $199 per month, compared to the much higher prices of branded options.
The commercial uses a provocative tone and visual style, aiming to stand out during an event typically dominated by lighthearted ads for snacks and beverages.
The ad underscores the company’s mission to make healthcare more accessible and positions Hims & Hers as a disruptive player in the growing $160 billion weight-loss industry.